Cargando…

Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization

OBJECTIVES: Sinonasal mucormycosis is a serious fungal infection. Early diagnosis and prompt antifungal therapy along with surgical intervention is the key to its management. Liposomal amphotericin B (LAmB) given intravenously is the antifungal agent of choice. However, the current literature is not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kajal, Smile, Naeem, Syed Shariq, Gupta, Pooja, Kairo, Arvind Kumar, Ahmed, Anam, Verma, Prankur, Saini, Ashish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249146/ https://www.ncbi.nlm.nih.gov/pubmed/35546459 http://dx.doi.org/10.4103/ijp.ijp_644_21

Ejemplares similares

Duration of Antibiotic Prophylaxis for Cochlear Implantation: A Systematic Review
por: Kajal, Smile, et al.
Publicado: (2022)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Bronchoscopic instillation of liposomal amphotericin B in management of nonresponding endobronchial mucormycosis
por: Nattusamy, Loganathan, et al.
Publicado: (2017)

1554. Nebulized Liposomal Amphotericin B for Treatment of Murine Pulmonary Mucormycosis
por: Sandoval, Adilene, et al.
Publicado: (2019)

Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

Estimation of Serum Levels of Heavy Metals in Patients with Chronic Invasive Fungal Rhinosinusitis Before the COVID-19 Era: A Pilot Study
por: Kajal, Smile, et al.
Publicado: (2022)

745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

845. Clinical Outcomes in Patients Treated with High vs. Standard Dose Liposomal Amphotericin B for Invasive Mucormycosis
por: Valiante, Sarah, et al.
Publicado: (2023)

Amphotericin-B liposomal /mycophenolic acid/tacrolimus: Mucormycosis and lack of efficacy: 2 case reports
Publicado: (2021)

WCN23-0704 Liposomal amphotericin associated nephrotoxicity in patients with Mucormycosis: An epidemic in the midst of Pandemic
por: KISHAN, A., et al.
Publicado: (2023)

Where is my ear? – Cervical Chondrocutaneous Branchial Remnant
por: Kajal, Smile, et al.
Publicado: (2021)

Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report
por: Çagatay, Atahan A, et al.
Publicado: (2001)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022)

Combination of amphotericin B and caspofungin in the treatment of mucormycosis
por: Gargouri, Marwa, et al.
Publicado: (2019)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

Dexamethasone: Sinonasal mucormycosis and hyperglycaemia: case report
Publicado: (2021)

Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center
por: Mrig, Sumit, et al.
Publicado: (2022)

Prognostic Association of Liposomal Amphotericin B Doses Above 5 mg/kg/d in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan
por: Tashiro, Masato, et al.
Publicado: (2023)

843. Prognostic Association of Liposomal Amphotericin B Doses Above 5 mg/kg in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan
por: Tashiro, Masato, et al.
Publicado: (2023)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2019)

Desensitization to liposomal amphotericin B after anaphylaxis in a patient with COVID-19-associated mucormycosis – A case with review of literature
por: Swain, Satish, et al.
Publicado: (2022)

Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience
por: Ramamurthy, Lakshmi B, et al.
Publicado: (2022)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals
por: Wasmann, Roeland E, et al.
Publicado: (2020)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Frontal sinus stenting: A feasible option for post-traumatic recurrent giant mucocele compromising vision
por: Kajal, Smile, et al.
Publicado: (2022)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis
por: Rizvi, Syed Wajahat A, et al.
Publicado: (2023)

Evaluation of liposomal amphotericin B for the treatment of fungal keratitis in a tertiary eye care hospital
por: Kumar, Vishal, et al.
Publicado: (2023)

Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023)

Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
por: Liu, Juntao, et al.
Publicado: (2023)

Retrospective analysis of the role of retrobulbar amphotericin-B injection in the management of COVID-19 associated rhino-orbito-cerebral-mucormycosis
por: Yadav, Rekha, et al.
Publicado: (2022)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
por: Kotha, C.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4bp3r1rpeju69r7qisqtoq7k5h